Astel­las shed­ding 600-plus jobs as CEO shakes up R&D and sales ops in re­struc­tur­ing

As Astel­las pres­i­dent and CEO Ken­ji Ya­sukawa maps out a strate­gic plan for the com­pa­ny he’s just re­cent­ly tak­en over, he’s al­so pre­scribed a round of re­struc­tur­ing with a goal to cut at least 600 em­ploy­ees through an ear­ly re­tire­ment scheme.

The Japan­ese com­pa­ny is look­ing at an over­haul in R&D and sales and mar­ket­ing as well as re­struc­tur­ing its group com­pa­nies in Japan. That means shut­ting down Astel­las Re­search Tech­nolo­gies, Astel­las Mar­ket­ing and Sales Sup­port, and Astel­las Learn­ing In­sti­tute. It’s al­so plan­ning to di­vest Astel­las An­a­lyt­i­cal Sci­ence Lab­o­ra­to­ries to Eu­rofins Phar­ma Ser­vices by the end of this fis­cal year.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.